Pecori Giraldi Francesca, Pivonello Rosario, Ambrogio Alberto Giacinto, De Martino Maria Cristina, De Martin Martina, Scacchi Massimo, Colao Annamaria, Toja Paola Maria, Lombardi Gaetano, Cavagnini Francesco
Department of Endocrinology, University of Milan, Ospedale San Luca, Istituto Auxologico Italiano, IRCCS, Milan, Italy.
Clin Endocrinol (Oxf). 2007 Feb;66(2):251-7. doi: 10.1111/j.1365-2265.2006.02717.x.
Cushing's syndrome (CS), when fully expressed, is easily diagnosed. Mild cases, however, may require careful distinction from pseudo-Cushing's states as may occur in depression, alcoholism, polycystic ovary disease and visceral obesity. The aim of the present study is a reappraisal of the diagnostic accuracy of the two tests most commonly used to differentiate CS from pseudo-Cushing's: corticotropin-releasing hormone (CRH) stimulation after low dose dexamethasone administration and desmopressin stimulation.
The study population comprised 32 patients with CS and 23 with pseudo-Cushing's evaluated retrospectively.
Urinary free cortisol (UFC), serum cortisol at midnight and after low dose dexamethasone (1 mg overnight and 2 mg over two days) were measured. Further, patients were tested with dexamethasone + CRH and desmopressin and the diagnostic performances of the two tests were compared in the entire series as well as in patients with mild hypercortisolism only (i.e. UFC < 690 nmol/24 h).
As expected, measurement of UFC, assessment of cortisol rhythmicity and inhibition after 1 mg/2 mg dexamethasone failed to clearly classify patients with pseudo-Cushing's. Administration of CRH following 2-mg dexamethasone achieved 100% sensitivity but 62.5% specificity. Conversely, desmopressin testing correctly classified all but two patients with pseudo-Cushing's (90% specificity) with 81.5% sensitivity. Diagnostic accuracy was comparable in the subgroup with mild hypercortisolism (21 CS, all 23 pseudo-Cushing's patients). Desmopressin offered an incremental diagnostic effectiveness of 35.8/million inhabitants compared with dexamethasone + CRH as a second-line test.
Neither of the two tests guarantees absolute diagnostic accuracy. The specificity of dexamethasone + CRH is less brilliant than previously reported and appears to be inferior to desmopressin stimulation. The greatest diagnostic effectiveness results from the low-dose dexamethasone test combined with the desmopressin test. Skilful use of dynamic testing and balanced clinical judgement are necessary to distinguish between Cushing's syndrome and pseudo-Cushing's.
库欣综合征(CS)典型表现时易于诊断。然而,轻度病例可能需要与假性库欣状态仔细鉴别,后者可见于抑郁症、酒精中毒、多囊卵巢疾病及内脏性肥胖。本研究旨在重新评估两种最常用于区分CS与假性库欣状态的检查的诊断准确性:小剂量地塞米松给药后促肾上腺皮质激素释放激素(CRH)刺激试验和去氨加压素刺激试验。
对32例CS患者和23例假性库欣患者进行回顾性评估。
测定尿游离皮质醇(UFC)、午夜血清皮质醇以及小剂量地塞米松(夜间1mg及两日共2mg)给药后的血清皮质醇。此外,对患者进行地塞米松+CRH及去氨加压素试验,并在整个队列以及仅患有轻度皮质醇增多症(即UFC<690nmol/24h)的患者中比较两种检查的诊断效能。
正如预期,UFC测定、皮质醇节律评估及1mg/2mg地塞米松给药后的抑制试验未能明确区分假性库欣患者。2mg地塞米松给药后给予CRH试验的敏感性达100%,但特异性为62.5%。相反,去氨加压素试验除两例假性库欣患者外均正确分类(特异性90%),敏感性为81.5%。在轻度皮质醇增多症亚组(21例CS患者,全部23例假性库欣患者)中诊断准确性相当。作为二线检查,与地塞米松+CRH相比,去氨加压素的诊断效能增加了35.8/百万居民。
两种检查均不能保证绝对的诊断准确性。地塞米松+CRH的特异性不如先前报道的那样出色,似乎低于去氨加压素刺激试验。最大的诊断效能来自小剂量地塞米松试验联合去氨加压素试验。熟练运用动态试验及平衡的临床判断对于区分库欣综合征和假性库欣综合征很有必要。